Sc. Miller et al., INTERMITTENT PARATHYROID-HORMONE ADMINISTRATION STIMULATES BONE-FORMATION IN THE MANDIBLES OF AGED OVARIECTOMIZED RATS, Journal of dental research, 76(8), 1997, pp. 1471-1476
Intermittent administration of parathyroid hormone (PTH) is known to s
timulate bone formation in many skeletal sites and is being investigat
ed as a possible therapeutic agent for the treatment of osteopenic con
ditions, including post-menopausal osteoporosis. The purpose of this s
tudy was to determine the ability of PTH to stimulate bone formation i
n the mandibles of aged ovariectomized (Ovx) rats, and the results are
compared with a site in the appendicular skeleton (humerus). The Ovx
rat is a useful model of estrogen deficiency, replicating many aspects
of post-menopausal osteoporosis. Female rats were ovariectomized or s
ham-operated, and one year later a group of the ovariectomized rats wa
s treated with the 1-34 fragment of human PTH daily, five days a week
for 10 weeks. During the experiment, the animals were given fluorochro
me bone markers for histomorphometry. More than one year after ovariec
tomy or sham surgery, there were few differences in the histomorphomet
ric indices of bone formation in the humerus or mandible. PTH treatmen
t had no effect on dentin formation, measured in the mandibular inciso
r; however, most indices of bone formation-including the double-labele
d surface, mineralizing surface, mineral appositional rate, new bone a
rea, and surface-referent bone formation rates-were substantially grea
ter in the PTH-treated group compared with both the Ovx and the Sham c
ontrols measured at the periosteal and endocortical surfaces of the hu
merus and the periosteal and cancellous bone surfaces of the mandible.
Ln addition, bone formation at the alveolar crest, particularly on th
e buccal side, was greater in the PTH-treated group. The results from
this study demonstrate that systemic intermittent PTH treatment stimul
ates bone formation in the mandibles in aged, estrogen-deficient anima
ls.